We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Highly Sensitive Molecular Test Developed for Tuberculosis

By LabMedica International staff writers
Posted on 15 Sep 2014
Rapid, accurate detection of Mycobacterium tuberculosis is crucial in the diagnosis of tuberculosis (TB), but conventional diagnostic methods have limited sensitivity and specificity or are time consuming.

A new highly sensitive nucleic acid amplification (NAA) test, combined nested and real-time polymerase chain reaction (PCR) in a single tube, one-tube nested real-time PCR, was developed for detecting M. More...
tuberculosis, which takes advantages of two PCR techniques, including real-time PCR.

Biomedical Laboratory Scientists at Yonsei University (Wonju, Republic of Korea) and their colleagues collected sputum specimens from 167 subjects having active TB and from 108 healthy subjects. Sputum specimens were liquefied and processed and the sediment were suspended in sterile saline and used for smear preparation, inoculation into Löwenstein-Jensen (LJ) media and DNA extraction. The presence of acid fast bacilli (AFB) was examined using a light microscope and the results of AFB smear were graded.

Initial identification of M. tuberculosis was confirmed using the SD TB Ag MPT64 immunochromatographic test (SD Bioline Inc.; Yongin, Korea) and the REBA Myco-ID molecular diagnostic kit (M&D Inc.; Wonju, Korea). The scientists designed a one-tube nested real-time PCR to have two sequential reactions with two sets of primers and dual probes for the IS6110 sequence of M. tuberculosis in a single closed tube. A real-time PCR assays were performed and validated using an Applied Biosystems 7500 Fast Real-time PCR System (Foster City, CA, USA).

The minimum limits of detection of IS6110 real-time PCR was 100 fg/μL and for the IS6110 one-tube nested real-time PCR it was 1 fg/μL of M. tuberculosis DNA. AdvanSure TB/NTM real-time PCR (LG Life Science; Seoul, Korea), IS6110 real-time PCR, and one-tube nested real-time PCR showed 100% sensitivity and 100% specificity for clinical M. tuberculosis isolates and nontuberculous mycobacteria (NTM) isolates. In comparison, the sensitivities of AdvanSure TB/NTM real-time PCR was 91% (152/167), 94.6% (158/167) for the single IS6110 real-time PCR, and 100% (167/167) one-tube nested real-time PCR.

The authors concluded that the new efficient, highly sensitive PCR assay, one-tube nested real-time PCR targeting IS6110 sequence that was developed for detecting M. tuberculosis, utilizes the advantages of nested PCR and real-time PCR. One-tube nested real-time PCR showed superior sensitivity to conventional real-time PCR and AdvanSure TB/NTM real-time PCR, a commercial TB real-time PCR kit. The study was published on August 30, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Yonsei University 
SD Bioline Inc.
M&D Inc.




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.